메뉴 건너뛰기




Volumn 48, Issue 6, 1996, Pages 901-905

Combined finasteride and flutamide therapy in men with advanced prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FINASTERIDE; FLUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

EID: 0030468455     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00315-9     Document Type: Article
Times cited : (79)

References (25)
  • 1
    • 0024563683 scopus 로고
    • Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma
    • Peeling WB: Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma. Urology 33(suppl): 45-52, 1989.
    • (1989) Urology , vol.33 , Issue.SUPPL. , pp. 45-52
    • Peeling, W.B.1
  • 2
    • 0021721387 scopus 로고
    • Leuprolide versus diethylstilbestrol for metastatic prostate cancer
    • The Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 311: 1281-1286, 1984.
    • (1984) N Engl J Med , vol.311 , pp. 1281-1286
  • 3
    • 0026687613 scopus 로고
    • Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer
    • Matzkin H, Eber P, Todd B, Van der Zwaag R, and Soloway M: Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer. Cancer 70: 2302-2309, 1992.
    • (1992) Cancer , vol.70 , pp. 2302-2309
    • Matzkin, H.1    Eber, P.2    Todd, B.3    Van Der Zwaag, R.4    Soloway, M.5
  • 4
    • 0026525245 scopus 로고
    • The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer
    • Miller JI, Ahmann FR, Drach GW, Emerson SS, and Bottaccini MR: The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J Urol 147: 956-961, 1992.
    • (1992) J Urol , vol.147 , pp. 956-961
    • Miller, J.I.1    Ahmann, F.R.2    Drach, G.W.3    Emerson, S.S.4    Bottaccini, M.R.5
  • 5
    • 0027479818 scopus 로고
    • Prostate cancer: Primary hormonal treatment
    • Denis L: Prostate cancer: primary hormonal treatment. Cancer 71(suppl): 1050-1058, 1993.
    • (1993) Cancer , vol.71 , Issue.SUPPL. , pp. 1050-1058
    • Denis, L.1
  • 6
    • 0027998956 scopus 로고
    • Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma
    • Karling P, Hammer M, and Varenhorst E: Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol 152: 1170-1173, 1994.
    • (1994) J Urol , vol.152 , pp. 1170-1173
    • Karling, P.1    Hammer, M.2    Varenhorst, E.3
  • 8
    • 0027479819 scopus 로고
    • Antiandrogenic agents as monotherapy in advanced prostatic carcinoma
    • Soloway MS, and Matzkin H: Antiandrogenic agents as monotherapy in advanced prostatic carcinoma. Cancer 71(suppl): 1083-1088, 1994.
    • (1994) Cancer , vol.71 , Issue.SUPPL. , pp. 1083-1088
    • Soloway, M.S.1    Matzkin, H.2
  • 9
    • 33646329223 scopus 로고
    • A double-blind randomized study of primary treatment for stage D2 prostate cancer: Diethylstilbestrol (DES) vs flutamide (F)
    • abstract 21
    • Chang A, Yeap B, Blum R, Hahn R, Khanna O, Fisher H, Witte R, and Trump D: A double-blind randomized study of primary treatment for stage D2 prostate cancer: diethylstilbestrol (DES) vs flutamide (F) (abstract). Proc Annu Meet Am Soc Clin Oncol 11: abstract 21, 1992.
    • (1992) Proc Annu Meet Am Soc Clin Oncol , vol.11
    • Chang, A.1    Yeap, B.2    Blum, R.3    Hahn, R.4    Khanna, O.5    Fisher, H.6    Witte, R.7    Trump, D.8
  • 10
    • 0028886697 scopus 로고
    • Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
    • Chodak G, Sharifi R, Kasimis B, Block NL, Macramalla E, and Kennealey GT: Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology 46: 849-855, 1995.
    • (1995) Urology , vol.46 , pp. 849-855
    • Chodak, G.1    Sharifi, R.2    Kasimis, B.3    Block, N.L.4    Macramalla, E.5    Kennealey, G.T.6
  • 11
    • 0025975824 scopus 로고
    • Physiologic basis of endocrine therapy for prostatic cancer
    • McConnell JD: Physiologic basis of endocrine therapy for prostatic cancer. Urol Clin North Am 18: 1-13, 1991.
    • (1991) Urol Clin North Am , vol.18 , pp. 1-13
    • McConnell, J.D.1
  • 12
    • 0022639044 scopus 로고
    • Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
    • Simard J, Luthy I, Belanger A, and Labrie F: Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 44: 261-270, 1986.
    • (1986) Mol Cell Endocrinol , vol.44 , pp. 261-270
    • Simard, J.1    Luthy, I.2    Belanger, A.3    Labrie, F.4
  • 13
  • 15
    • 0026644386 scopus 로고
    • Multicenter, randomized double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer
    • Presti JC, Fair WR, Andriole GL, Sogani PC, Seidmon EJ, Ferguson D, Ng J, and Gormley GJ: Multicenter, randomized double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer. J Urol 148: 1201-1204, 1992.
    • (1992) J Urol , vol.148 , pp. 1201-1204
    • Presti, J.C.1    Fair, W.R.2    Andriole, G.L.3    Sogani, P.C.4    Seidmon, E.J.5    Ferguson, D.6    Ng, J.7    Gormley, G.J.8
  • 17
    • 0026449007 scopus 로고
    • Sequential androgen blockade: A biological study in the inhibition of prostatic growth
    • Fleshner NE, and Trachtenberg J: Sequential androgen blockade: a biological study in the inhibition of prostatic growth. J Urol 148: 1928-1931, 1992.
    • (1992) J Urol , vol.148 , pp. 1928-1931
    • Fleshner, N.E.1    Trachtenberg, J.2
  • 18
    • 0027500026 scopus 로고
    • Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of flutamide and 4-MA
    • Martel C, Claude T, Couet J, Labrie C, Belanger A, and Labrie F: Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of flutamide and 4-MA. Mol Cell Endocrinol 91: 43-49, 1993.
    • (1993) Mol Cell Endocrinol , vol.91 , pp. 43-49
    • Martel, C.1    Claude, T.2    Couet, J.3    Labrie, C.4    Belanger, A.5    Labrie, F.6
  • 19
    • 0027879182 scopus 로고
    • Serum PSA after antiandrogen therapy
    • Petros J, and Andriole GL: Serum PSA after antiandrogen therapy. Urol Clin North Am 20: 749-756, 1993.
    • (1993) Urol Clin North Am , vol.20 , pp. 749-756
    • Petros, J.1    Andriole, G.L.2
  • 20
    • 0025648064 scopus 로고
    • Prognostic significance of prostate specific antigen in endocrine treatment for prostate cancer
    • Arai Y, Yoshiki T, and Yoshida O: Prognostic significance of prostate specific antigen in endocrine treatment for prostate cancer. J Urol 144: 1415-1419, 1990.
    • (1990) J Urol , vol.144 , pp. 1415-1419
    • Arai, Y.1    Yoshiki, T.2    Yoshida, O.3
  • 22
    • 0028799960 scopus 로고
    • Combination finasteride and flutamide in advanced carcinoma of the prostate: Effective therapy with minimal side effects
    • Fleshner NE, and Trachtenberg J: Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects. J Urol 154: 1642-1646, 1995.
    • (1995) J Urol , vol.154 , pp. 1642-1646
    • Fleshner, N.E.1    Trachtenberg, J.2
  • 23
    • 33646275441 scopus 로고    scopus 로고
    • Finasteride and flutamide as potency-sparing androgen ablative therapy for advanced prostate cancer
    • Brufsky A, Fontaine-Rothe P, Berlane IK, Kaplan I, and Kantoff P: Finasteride and flutamide as potency-sparing androgen ablative therapy for advanced prostate cancer. Proc Am Soc Clin Oncol 15: 252, 1996.
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 252
    • Brufsky, A.1    Fontaine-Rothe, P.2    Berlane, I.K.3    Kaplan, I.4    Kantoff, P.5
  • 25
    • 0028864735 scopus 로고
    • A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer
    • Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, and Kolvenbag G: A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Urology 45: 745-752, 1995.
    • (1995) Urology , vol.45 , pp. 745-752
    • Schellhammer, P.1    Sharifi, R.2    Block, N.3    Soloway, M.4    Venner, P.5    Patterson, A.L.6    Sarosdy, M.7    Vogelzang, N.8    Jones, J.9    Kolvenbag, G.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.